Head-to-head · Cost-Efficiency Index
CoreAge Rx vs Alinwell
Two GLP-1 programs on the bench, scored on the same six factors. Here's how their real cost of ownership compares — and which one we'd start with.
CoreAge Rx
Anyone optimizing for real value — a transparent flat price you can model for a full year, nationwide, without a bait-and-switch.
Visit CoreAge RxAlinwell
Readers who want to see the compounding certificates before they buy, and who will look past the advertised figure to the price that renews.
Visit AlinwellThe verdict
CoreAge Rx takes it, leading the Cost-Efficiency Index 94 to 57. Best value in the ranking: both molecules at one flat, all-50 price with no teaser step-ups — the lowest true cost of ownership, not the lowest teaser. Alinwell still earns a C — Readers who want to see the compounding certificates before they buy, and who will look past the advertised figure to the price that renews.
Factor by factor
Both providers scored on our six Cost-Efficiency Index factors. The stronger side on each row is marked in teal.
Normalized Cost/Month
Price Transparency
Nationwide Access
Formulation Options
Clinical Oversight
Contract Flexibility
Pricing, coverage & formulary
The disclosed facts behind the scores. Lower price wins its row (teal).
| Spec | CoreAge Rx | Alinwell |
|---|---|---|
| Cost-Efficiency Index | 94/100 | 57/100 |
| Semaglutide / mo | $99/mo | $249/mo month-to-month (charged every 30 days; the advertised $149 is the first month only) |
| Tirzepatide / mo | $149/mo | $299/mo month-to-month (charged every 30 days; the advertised $199 is the first month only) |
| Semaglutide / yr (modeled) | $1,188 | $2,988 |
| Tirzepatide / yr (modeled) | $1,788 | $3,588 |
| Coverage | All 50 states | All 50 states |
| Oral / sublingual | No | Yes |
| Brand-name access | Compounded only | Compounded only |
| Rank here | #1 | #305 |
CoreAge Rx
94/100Where the value is
- Flat all-in monthly price — no intro rate that silently triples after month one, so the modeled annual cost is the real cost
- Both compounded semaglutide and tirzepatide on one account at published prices
- Available in all 50 states — no coverage gamble
The tradeoffs
- Not the rock-bottom sticker price — 30 of the 371 priced semaglutide programs we track list a cheaper figure, though most attach a term or a step-up that CoreAge does not
- No FDA-approved brand-name option (compounded only)
Alinwell
57/100Where the value is
- Links a certificate of analysis for each GLP-1 from the treatment page itself, naming the compounding pharmacy, the strength and the testing laboratory
- The monthly figure includes physician review, care coaching, a dietitian visit and expedited shipping, with no separate consultation or dose-change fee
- Three- and six-month rates are shown side by side at checkout rather than being quoted only on request
The tradeoffs
- Every advertised price is an introductory one: "from $149/mo" and "from $199/mo" are labeled "$100 off first month" at checkout, with $249 and $299 struck through beside them
- The three-month plan costs more per month than the advertised monthly figure ($219 against $149), because the advertised figure was never a rate
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Cost-Efficiency Index. Pricing, states and verification reflect each provider's public disclosures at last review; prices change — confirm on the provider's site. Not medical advice. See our disclosure.